3rd TGF-β for Immuno-Oncology Drug Development Summit
Unlocking the Double-Edged Sword of TGF-β to Harness the Therapeutic Potential for Immuno-Oncology
ExploitUnderstanding of TGF-β Biology, Harness Clinically Validated Biomarkers & Advance Safe & Efficacious Clinical Programs for Maximal Therapeutics Benefit in Immuno-Oncology
In the past year alone, the field has learnt valuable lessons from the clinical trials and from the wider TGF-β field that will equip the immuno-oncology field with the knowledge needed to supercharge future TGF-β monotherapy or combinational therapeutics for precision medicine.
From uncovering the effects and production of TGF-β in immune, tumor and stromal cells to exploring predictive and pharmacodynamic TGF-β biomarkers for patient identification and assessing the clinical challenges that led to recent clinical failures, the 3rd TGF-β for Immuno-Oncology Drug Development Summit is your one-stop-shop dedicated to harnessing you with the knowledge to unlock the potential of successfully targeting TGF-β.
Tailored with 18+ senior leaders, the 2023 meeting will be taking place in-person for the first time - don't miss your chance to be in the room for your comprehensive guide on TGF-β in immuno-oncology!
Whether you are new to this field or a seasoned expert, this meeting will provide you with the must-know takeaways from the basic biology to biomarkers to clinical trial design to overcome the clinical setbacks and produce a blockbuster TGF-β therapeutic.
Sat, 11 Feb 2023 - Mon, 13 Feb 2023
United Arab Emirates
Sun, 19 Feb 2023 - Wed, 22 Feb 2023
San Antonio, Texas 78261
Sat, 25 Feb 2023 - Sun, 26 Feb 2023
Mon, 27 Feb 2023 - Mon, 27 Feb 2023